Trastuzumab Deruxtecan
Auto-discovered · not yet curatedtrastuzumab deruxtecan
Educational only, not medical advice. OncoForge makes no claim that Trastuzumab Deruxtecan treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.
Simple Summary
Auto-discovered from 1 recent study; not yet curated.
Research
No published studies for Trastuzumab Deruxtecan yet
New studies appear here once they’ve been reviewed. Browse all studies.
Trials studying Trastuzumab Deruxtecan
101 recruiting on ClinicalTrials.gov. Recruiting is not the same as proven. Search ClinicalTrials.gov →
- Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.NCT07407465Phase 2Recruiting
- HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBCNCT06830382Recruiting
- Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in KoreaNCT06928818Recruiting
- The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast CancerNCT06439693Phase 2Recruiting
- Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)NCT06809764Recruiting
Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.